| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_058e0be30e00d53858c67167df60aed5 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K5-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K5-06078
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D233-64 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-415
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C317-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D233-64
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D233-54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K5-065
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K5-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-55
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-165
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C237-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-81 |
| filingDate |
1991-06-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
1993-12-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4aec8b136373e107b554534e3142ee21
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b848976a985a5b8e350037b6aef55ad6 |
| publicationDate |
1993-12-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-5268361-A |
| titleOfInvention |
Hydroxyazido derivatives and related compounds as renin inhibitors |
| abstract |
Novel compounds useful as renin inhibitors are provided. The compounds are hydroxyazido derivatives having the structural formula <IMAGE> wherein the substituents R1 through R7 are as defined herein. Analogs of these compounds which are ketozaido derivatives are also provided. Additionally disclosed re methods for using the novel compounds to treat hypertension, and pharmaceutical compositions containing the compounds. Of particular interest are formulations for oral administration. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5888992-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007111989-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6071895-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-1103535-C
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008312242-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9507269-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005176700-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006217371-A1 |
| priorityDate |
1991-06-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |